Clinical trial
A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major…
NCT00435279 · Sumitomo Pharma America, Inc., Industry · Completed
Key facts
| NCT number | NCT00435279 |
|---|---|
| Title | A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia |
| Official title | A 31-Week, Efficacy, Safety and Tolerability Study of Eszopiclone 3 mg Co-administered With Venlafaxine in Subjects With Major Depressive Disorder (MDD) and Co-existing Insomnia |
| Lead sponsor | Sumitomo Pharma America, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder, Insomnia |
| Intervention type | Drug |
| Interventions | Eszopiclone, Placebo, Venlafaxine |
| Enrollment | 678 |
| Start date | Jun 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Feb 14, 2007 |
| Last update posted | Feb 22, 2012 |
| Countries | Austria, Croatia, France, Hungary, Poland, Romania, Russia, Serbia, Ukraine, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: